We improve the management of prostate cancer patients by developing machine learning-based prognostic models that can stratify patients into those that will benefit from additional diagnostic procedures and invasive treatments and those that do not.
We improve the management of prostate cancer patients by developing machine learning-based prognostic models that can stratify patients into those that will benefit from additional diagnostic procedures and invasive treatments and those that do not.
